-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018...
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the..
7 eco-friendly alternatives to plastic straws to help save the oceans..